Tuberculosis stands as one of the leading causes of death among young people across the world. Modeling studies suggest that in over 96% of the deadly cases involving children younger than 15 years ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

A clinical study that began in a research unit in Gqeberha (PE), Eastern Cape, has transformed global treatment of drug-resistant tuberculosis.

Tuberculosis (TB) latency involves infection with the bacteria that also cause active TB. However, people with TB latency do not have symptoms. Treatment for TB latency can help reduce the risk of ...